ResearcherHuazhong University of Science and TechnologyNo recent work listed

Bo Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-9750-179X; OpenAlex author ID A5100408035. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 8

Papers, trials and grants by year

2018: 1 paper · 2019: 1 paper

Papers 2

B7-H3 is regulated by BRD4 and promotes TLR4 expression in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.biocel.2019.01.011 ↗
FBP1 loss contributes to BET inhibitors resistance by undermining c-Myc expression in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s13046-018-0888-y ↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jingyuan Zhao · 2 shared papers, 2018–2019 · strength 0.19
- Paper FBP1 loss contributes to BET inhibitors resistance by undermining c-Myc expression in pancreatic ductal adenocarcinoma. DOI 10.1186/s13046-018-0888-y ↗
- Paper B7-H3 is regulated by BRD4 and promotes TLR4 expression in pancreatic ductal adenocarcinoma. DOI 10.1016/j.biocel.2019.01.011 ↗
Ping Fan · 2 shared papers, 2018–2019 · strength 0.19
- Paper FBP1 loss contributes to BET inhibitors resistance by undermining c-Myc expression in pancreatic ductal adenocarcinoma. DOI 10.1186/s13046-018-0888-y ↗
- Paper B7-H3 is regulated by BRD4 and promotes TLR4 expression in pancreatic ductal adenocarcinoma. DOI 10.1016/j.biocel.2019.01.011 ↗
Heshui Wu · 2 shared papers, 2018–2019 · strength 0.19
- Paper FBP1 loss contributes to BET inhibitors resistance by undermining c-Myc expression in pancreatic ductal adenocarcinoma. DOI 10.1186/s13046-018-0888-y ↗
- Paper B7-H3 is regulated by BRD4 and promotes TLR4 expression in pancreatic ductal adenocarcinoma. DOI 10.1016/j.biocel.2019.01.011 ↗
Xin Jin · 2 shared papers, 2018–2019 · strength 0.19
- Paper FBP1 loss contributes to BET inhibitors resistance by undermining c-Myc expression in pancreatic ductal adenocarcinoma. DOI 10.1186/s13046-018-0888-y ↗
- Paper B7-H3 is regulated by BRD4 and promotes TLR4 expression in pancreatic ductal adenocarcinoma. DOI 10.1016/j.biocel.2019.01.011 ↗
Chong Yang · 1 shared paper, 2019 · strength 0.09
- Paper B7-H3 is regulated by BRD4 and promotes TLR4 expression in pancreatic ductal adenocarcinoma. DOI 10.1016/j.biocel.2019.01.011 ↗
Zibo Meng · 1 shared paper, 2019 · strength 0.09
- Paper B7-H3 is regulated by BRD4 and promotes TLR4 expression in pancreatic ductal adenocarcinoma. DOI 10.1016/j.biocel.2019.01.011 ↗
Zhiqiang Liu · 1 shared paper, 2019 · strength 0.09
- Paper B7-H3 is regulated by BRD4 and promotes TLR4 expression in pancreatic ductal adenocarcinoma. DOI 10.1016/j.biocel.2019.01.011 ↗
Shihong Wu · 1 shared paper, 2019 · strength 0.09
- Paper B7-H3 is regulated by BRD4 and promotes TLR4 expression in pancreatic ductal adenocarcinoma. DOI 10.1016/j.biocel.2019.01.011 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.